AstraZeneca, Bristol-Myers Squibb, and Amgen are Reshaping the Pharma Sector
The pharmaceutical sector has seen a fascinating evolution in the United States, owing to the influence of the global health crisis, burgeoning alliances across the supply chain, and constant policy changes. The introduction of strategic acquisitions ranging between $1–$5 billion,…
